| Year |
Citation |
Score |
| 2023 |
Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R, Darst BF, Sheng X, Xu Y, Chou AJ, Benlloch S, Dadaev T, Brook MN, Plym A, Sahimi A, ... ... Rebbeck TR, et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nature Genetics. PMID 37945903 DOI: 10.1038/s41588-023-01534-4 |
0.334 |
|
| 2023 |
Chen F, Madduri RK, Rodriguez AA, Darst BF, Chou A, Sheng X, Wang A, Shen J, Saunders EJ, Rhie SK, Bensen JT, Ingles SA, Kittles RA, Strom SS, Rybicki BA, ... ... Rebbeck TR, et al. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. European Urology. PMID 36872133 DOI: 10.1016/j.eururo.2023.01.022 |
0.307 |
|
| 2022 |
Friebel-Klingner TM, Bazzett-Matabele L, Ramogola-Masire D, Monare B, Ralefala TB, Seiphetlheng A, Ramontshonyana G, Vuylsteke P, Mitra N, Wiebe DJ, Rebbeck TR, McCarthy AM, Grover S. Distance to Multidisciplinary Team Clinic in Gaborone, Botswana, and Stage at Cervical Cancer Presentation for Women Living With and Without HIV. Jco Global Oncology. 8: e2200183. PMID 36395437 DOI: 10.1200/GO.22.00183 |
0.454 |
|
| 2022 |
Kim MS, Naidoo D, Hazra U, Quiver MH, Chen WC, Simonti CN, Kachambwa P, Harlemon M, Agalliu I, Baichoo S, Fernandez P, Hsing AW, Jalloh M, Gueye SM, Niang L, ... ... Rebbeck TR, et al. Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa. Genome Biology. 23: 194. PMID 36100952 DOI: 10.1186/s13059-022-02766-z |
0.322 |
|
| 2022 |
Friebel-Klingner TM, Iyer HS, Ramogola-Masire D, Bazzett-Matabele L, Monare B, Seiphetlheng A, Ralefala TB, Mitra N, Wiebe DJ, Rebbeck TR, Grover S, McCarthy AM. Evaluating the geographic distribution of cervical cancer patients presenting to a multidisciplinary gynecologic oncology clinic in Gaborone, Botswana. Plos One. 17: e0271679. PMID 35925976 DOI: 10.1371/journal.pone.0271679 |
0.459 |
|
| 2022 |
Li S, Silvestri V, Leslie G, Rebbeck TR, Neuhausen SL, Hopper JL, Nielsen HR, Lee A, Yang X, McGuffog L, Parsons MT, Andrulis IL, Arnold N, Belotti M, Borg Å, et al. Cancer Risks Associated With and Pathogenic Variants. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102112. PMID 35077220 DOI: 10.1200/JCO.21.02112 |
0.324 |
|
| 2022 |
Darst BF, Hughley R, Pfennig A, Hazra U, Fan C, Wan P, Sheng X, Xia L, Andrews C, Chen F, Berndt SI, Kote-Jarai Z, Govindasami K, Bensen JT, Ingles SA, ... ... Rebbeck TR, et al. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry. European Urology. PMID 35031163 DOI: 10.1016/j.eururo.2021.12.023 |
0.326 |
|
| 2021 |
Friebel-Klingner TM, Luckett R, Bazzett-Matabele L, Ralefala TB, Monare B, Nassali MN, Ramogola-Masire D, Bvochora M, Mitra N, Wiebe D, Rebbeck TR, McCarthy AM, Grover S. Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana. Bmc Women's Health. 21: 267. PMID 34229672 DOI: 10.1186/s12905-021-01402-5 |
0.469 |
|
| 2021 |
Wang V, Geybels MS, Jordahl KM, Gerke T, Hamid A, Penney KL, Markt SC, Freedman M, Pomerantz M, Lee GM, Rana H, Börnigen D, Rebbeck TR, Huttenhower C, Eeles RA, et al. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer. The Prostate. PMID 33956343 DOI: 10.1002/pros.24148 |
0.304 |
|
| 2021 |
Han D, Owiredu JN, Healy BM, Li M, Labaf M, Steinfeld JS, Patalano S, Gao S, Liu M, Macoska JA, Zarringhalam K, Siegfried KR, Yuan X, Rebbeck TR, Cai C. Susceptibility-associated genetic variation in NEDD9 contributes to prostate cancer initiation and progression. Cancer Research. PMID 33632899 DOI: 10.1158/0008-5472.CAN-20-3042 |
0.328 |
|
| 2020 |
Glubb DM, Thompson DJ, Aben KK, Alsulimani A, Amant F, Annibali D, Attia J, Barricarte A, Beckmann MW, Berchuck A, Bermisheva M, Bernardini MQ, Bischof K, Bjørge L, Bodelon C, ... ... Rebbeck TR, et al. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33144283 DOI: 10.1158/1055-9965.EPI-20-0739 |
0.312 |
|
| 2020 |
Silvestri V, Leslie G, Barnes DR, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Barkardottir RB, Barroso A, Barrowdale D, Benitez J, Bonanni B, Borg A, Buys SS, ... ... Rebbeck TR, et al. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Jama Oncology. PMID 32614418 DOI: 10.1001/Jamaoncol.2020.2134 |
0.336 |
|
| 2020 |
Fadelu T, Damuse R, Lormil J, Pecan E, Dubuisson C, Pierre V, Rebbeck T, Shulman LN. Patient Characteristics and Outcomes of Nonmetastatic Breast Cancer in Haiti: Results from a Retrospective Cohort. The Oncologist. PMID 32584461 DOI: 10.1634/Theoncologist.2019-0951 |
0.36 |
|
| 2020 |
Harlemon M, Ajayi O, Kachambwa P, Kim MS, Simonti CN, Quiver MH, Petersen DC, Mittal A, Fernandez PW, Hsing AW, Baichoo S, Agalliu I, Jalloh M, Gueye SM, Snyper NYF, ... ... Rebbeck TR, et al. A custom genotyping array reveals population-level heterogeneity for the genetic risks of prostate cancer and other cancers in Africa. Cancer Research. PMID 32393663 DOI: 10.1158/0008-5472.CAN-19-2165 |
0.337 |
|
| 2020 |
Kensler K, Pernar C, Mahal B, Nguyen P, Trinh Q, Kibel A, Rebbeck T. PSA Testing and Prostate Cancer Incidence Following the 2012 Update to the U.S. Preventive Services Task Force Prostate Cancer Screening Recommendation: Implications for Racial/Ethnic Disparities Cancer Epidemiology Biomarkers & Prevention. 29: 694.1-694. DOI: 10.1158/1055-9965.Epi-20-0066 |
0.384 |
|
| 2019 |
Patel VL, Busch EL, Friebel TM, Cronin A, Leslie G, McGuffog L, Adlard J, Agata S, Agnarsson BA, Ahmed M, Aittomäki K, Alducci E, Andrulis IL, Arason A, Arnold N, ... ... Rebbeck TR, et al. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. Cancer Research. PMID 31723001 DOI: 10.1158/0008-5472.Can-19-1840 |
0.314 |
|
| 2019 |
Hamajima N, Hirose K, Tajima K, Rohan T, Friedenreich C, Gapstur S, Gaudet M, Coates R, Liff J, Kakouri E, Marcou Y, Duffy S, Morabia A, Schuman L, Stewart W, ... ... Rebbeck T, et al. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence The Lancet. 394: 1159-1168. PMID 31474332 DOI: 10.1016/S0140-6736(19)31709-X |
0.37 |
|
| 2019 |
Mahal AR, Butler S, Franco I, Muralidhar V, Larios D, Pike LRG, Zhao SG, Sanford NN, Dess RT, Feng FY, D'Amico AV, Spratt DE, Yu JB, Nguyen PL, Rebbeck TR, et al. Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database. Cancer. PMID 31251398 DOI: 10.1200/Jco.2019.37.7_Suppl.12 |
0.346 |
|
| 2019 |
Lu-Yao GL, Nikita N, Keith SW, Banks J, Handley N, Rebbeck T, Cullen J, Domingo-Domenech J, Kelly WK. Racial differences in long-term prostate cancer specific mortality following conservative management for low-risk prostate cancer: A population-based study. Journal of Clinical Oncology. 37: 121-121. DOI: 10.1200/Jco.2019.37.7_Suppl.121 |
0.413 |
|
| 2019 |
Butler S, Franco II, Mahal AR, Sanford NN, Trinh Q, Rebbeck T, Nguyen PL, D'Amico AV, Mahal BAV. “Management Migration” in United States patients diagnosed with localized prostate cancer from 2010-2015. Journal of Clinical Oncology. 37: 11-11. DOI: 10.1200/Jco.2019.37.7_Suppl.11 |
0.377 |
|
| 2019 |
Butler S, Muralidhar V, D'Amico AV, Nguyen PL, Rebbeck T, Mahal BAV. Active surveillance and watchful waiting for low-risk prostate cancer in black patients: A population-based analysis. Journal of Clinical Oncology. 37: 10-10. DOI: 10.1200/Jco.2019.37.7_Suppl.10 |
0.352 |
|
| 2019 |
Fadelu T, Damuse R, Pecan L, Dubuisson C, Greenberg L, Danjoue S, Lormil JK, Rebbeck T, Shulman LN. Patient characteristics, treatment received, and outcomes of non-metastatic breast cancer patients in Haiti: Report from retrospective cohort. Journal of Clinical Oncology. 37: e18196-e18196. DOI: 10.1200/Jco.2019.37.15_Suppl.E18196 |
0.342 |
|
| 2019 |
Leo P, Janowczyk A, Elliott R, Janaki N, Shiradkar R, Farrè X, Yamoah K, Rebbeck T, Shih N, Khani F, Robinson BD, Eklund L, Ettala O, Taimen P, Bostrom P, et al. Computerized histomorphometric features of glandular architecture predict risk of biochemical recurrence following radical prostatectomy: A multisite study. Journal of Clinical Oncology. 37: 5060-5060. DOI: 10.1200/Jco.2019.37.15_Suppl.5060 |
0.331 |
|
| 2019 |
Lachance J, Harlemon M, Kachambwa P, Ajayi O, Kim M, Adams M, Pugh E, Peterson L, Rebbeck T. Abstract 2410: Development of a custom genotyping platform and genetic prediction of prostate cancer risks in sub-Saharan Africa Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-2410 |
0.402 |
|
| 2018 |
Zhao H, Mitra N, Kanetsky PA, Nathanson KL, Rebbeck TR. A practical approach to adjusting for population stratification in genome-wide association studies: principal components and propensity scores (PCAPS). Statistical Applications in Genetics and Molecular Biology. PMID 30507552 DOI: 10.1515/Sagmb-2017-0054 |
0.552 |
|
| 2018 |
O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, ... ... Rebbeck TR, et al. Identification of nine new susceptibility loci for endometrial cancer. Nature Communications. 9: 3166. PMID 30093612 DOI: 10.1038/S41467-018-05427-7 |
0.321 |
|
| 2018 |
Chuang L, Berek J, Randall T, McCormack M, Schmeler K, Manchanda R, Rebbeck T, Jeng CJ, Pyle D, Quinn M, Trimble E, Naik R, Lai CH, Ochiai K, Denny L, et al. Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities. Gynecologic Oncology Reports. 25: 65-69. PMID 29928684 DOI: 10.1016/J.Gore.2018.05.005 |
0.321 |
|
| 2018 |
Zhang L, Shin VY, Chai X, Zhang A, Chan TL, Ma ES, Rebbeck TR, Chen J, Kwong A. Breast and ovarian cancer penetrance of mutations among Hong Kong women. Oncotarget. 9: 25025-25033. PMID 29861850 DOI: 10.18632/oncotarget.24382 |
0.316 |
|
| 2018 |
Fadelu T, Damuse R, Pecan L, Greenberg L, Danjoue S, Lormil J, Rebbeck T, Shulman L. Association Between Living in Urban Areas and Obesity in Haitian Breast Cancer Patients Journal of Global Oncology. 4. DOI: 10.1200/Jgo.18.25600 |
0.35 |
|
| 2018 |
Lu-Yao GL, E J, Lin Y, Rebbeck T, Lu S, Kelly WK, D'Amico AV, Stein MN, Zhang L, Kim I, Demissie K, Ferrari AC, Tan X. Individual and joint effect of postdiagnostic metformin and statin use on prostate cancer mortality among patients with high-risk prostate cancer. Journal of Clinical Oncology. 36: 202-202. DOI: 10.1200/Jco.2018.36.6_Suppl.202 |
0.379 |
|
| 2018 |
Lu-Yao GL, Nightingale G, Nikita N, Patel SA, Gandhi K, Leiby B, Hegarty S, Barsevick AM, Padron N, Rebbeck T, Chapman AE, Gomella LG, Kelly WK. Clinical outcomes following androgen receptor axis therapies (ARAT) among men with prostate cancer (PCa) having major cardiovascular diseases (CVDs) or extreme polypharmacy (EPP): A population based study. Journal of Clinical Oncology. 36: 5056-5056. DOI: 10.1200/Jco.2018.36.15_Suppl.5056 |
0.348 |
|
| 2018 |
Bhargava HK, Leo P, Elliott R, Janowczyk A, Whitney J, Gupta S, Yamoah K, Rebbeck T, Feldman MD, Lal P, Madabhushi A. Computer-extracted stromal features of African-Americans versus Caucasians from H&E slides and impact on prognosis of biochemical recurrence. Journal of Clinical Oncology. 36: 12075-12075. DOI: 10.1200/Jco.2018.36.15_Suppl.12075 |
0.329 |
|
| 2017 |
Randall TC, Chuang L, Orang'o E, Rosen B, Uwinkindi F, Rebbeck T, Trimble EL. Strengthening care and research for women's cancers in Sub-Saharan Africa. Gynecologic Oncology Reports. 21: 109-113. PMID 28819635 DOI: 10.1016/J.Gore.2017.06.002 |
0.322 |
|
| 2017 |
Jordan SJ, Na R, Johnatty SE, Wise LA, Adami HO, Brinton LA, Chen C, Cook LS, Dal Maso L, De Vivo I, Freudenheim JL, Friedenreich CM, La Vecchia C, McCann SE, Moysich KB, ... ... Rebbeck TR, et al. Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium. Obstetrics and Gynecology. PMID 28486362 DOI: 10.1097/Aog.0000000000002057 |
0.306 |
|
| 2017 |
Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, Soucy P, Leslie G, Rizzolo P, Navazio AS, Valentini V, Zelli V, Lee A, Amin Al Olama A, Tyrer JP, ... ... Rebbeck TR, et al. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016694935. PMID 28448241 DOI: 10.1200/Jco.2016.69.4935 |
0.357 |
|
| 2017 |
Lynch SM, Mitra N, Ravichandran K, Mitchell J, Spangler E, Zhou W, Paskett ED, Gehlert S, DeGraffinreid C, Stowe R, Dubowitz T, Riethman H, Branas CC, Peek MK, Rebbeck TR. Telomere Length and Neighborhood Circumstances: Evaluating Biological Response to Unfavorable Exposures. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 26: 553-560. PMID 28373169 DOI: 10.1158/1055-9965.Epi-16-0554 |
0.434 |
|
| 2017 |
Lynch SM, Mitra N, Ross M, Newcomb C, Dailey K, Jackson T, Zeigler-Johnson CM, Riethman H, Branas CC, Rebbeck TR. A Neighborhood-Wide Association Study (NWAS): Example of prostate cancer aggressiveness. Plos One. 12: e0174548. PMID 28346484 DOI: 10.1371/Journal.Pone.0174548 |
0.479 |
|
| 2017 |
Rebbeck TR. Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography. Seminars in Radiation Oncology. 27: 3-10. PMID 27986209 DOI: 10.1016/j.semradonc.2016.08.002 |
0.31 |
|
| 2017 |
Narayan V, Lal P, Zeigler-Johnson C, Malkowicz SB, Rebbeck T. EZH2 expression and clinical outcome in African-American men with prostate cancer. Journal of Clinical Oncology. 35: 81-81. DOI: 10.1200/Jco.2017.35.6_Suppl.81 |
0.409 |
|
| 2017 |
Cullen J, Kuo H, Chen Y, Hurwitz L, Rosner IL, Porter C, Brand TC, Sterbis J, Stroup S, Rebbeck T, D'Amico AV, Lu-Yao GL. Prostate cancer outcomes for African American and caucasian patients undergoing radical prostatectomy. Journal of Clinical Oncology. 35: 40-40. DOI: 10.1200/Jco.2017.35.6_Suppl.40 |
0.367 |
|
| 2017 |
Cullen J, Kuo H, Hurwitz L, Rosner IL, Rebbeck T, D'Amico AV, Lu-Yao GL. Predictors of post-surgical race-specific prostate cancer progression. Journal of Clinical Oncology. 35: 5048-5048. DOI: 10.1200/Jco.2017.35.15_Suppl.5048 |
0.367 |
|
| 2017 |
Lachance J, Berens A, Hansen M, Teng A, Tishkoff S, Rebbeck T. Abstract A33: Population and evolutionary genomics of prostate cancer-associated variants: implications for health disparities in men of African descent Cancer Research. 77. DOI: 10.1158/1538-7445.Newfront17-A33 |
0.445 |
|
| 2017 |
Patel V, Busch E, Cronin A, Pomerantz M, Freedman M, D'Amico A, Rebbeck T. Germline BRCA2 Mutations in Men With Prostate Cancer Assort into Functional Cluster Regions International Journal of Radiation Oncology*Biology*Physics. 99: S32. DOI: 10.1016/J.Ijrobp.2017.06.087 |
0.348 |
|
| 2016 |
Huo D, Feng Y, Haddad S, Zheng Y, Yao S, Han YJ, Ogundiran TO, Adebamowo C, Ojengbede O, Falusi AG, Zheng W, Blot W, Cai Q, Signorello L, John EM, ... ... Rebbeck TR, et al. Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer. Human Molecular Genetics. 25: 4835-4846. PMID 28171663 DOI: 10.1093/Hmg/Ddw305 |
0.322 |
|
| 2016 |
Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL, Apostolou P, Arnold N, Arun BK, Barrowdale D, Benitez J, Berger R, Berthet P, Borg A, Buys SS, et al. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Research : Bcr. 18: 112. PMID 27836010 DOI: 10.1186/S13058-016-0768-3 |
0.397 |
|
| 2016 |
Hamdi Y, Soucy P, Kuchenbaeker KB, Pastinen T, Droit A, Lemaçon A, Adlard J, Aittomäki K, Andrulis IL, Arason A, Arnold N, Arun BK, Azzollini J, Bane A, Barjhoux L, ... ... Rebbeck T, et al. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast Cancer Research and Treatment. PMID 27796716 DOI: 10.1007/S10549-016-4018-2 |
0.451 |
|
| 2016 |
Huo D, Feng Y, Haddad S, Zheng Y, Yao S, Han YJ, Ogundiran TO, Adebamowo C, Ojengbede O, Falusi AG, Zheng W, Blot W, Cai Q, Signorello L, John EM, ... ... Rebbeck TR, et al. Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer. Human Molecular Genetics. PMID 27594435 DOI: 10.1093/hmg/ddw305 |
0.324 |
|
| 2016 |
Chen MM, O'Mara TA, Thompson DJ, Painter JN, Attia J, Black A, Brinton L, Chanock S, Chen C, Cheng TH, Cook LS, Crous-Bou M, Doherty J, Friedenreich CM, ... ... Rebbeck TR, et al. GWAS meta-analysis of 16,852 women identifies new susceptibility locus for endometrial cancer. Human Molecular Genetics. PMID 27008869 DOI: 10.1093/Hmg/Ddw092 |
0.31 |
|
| 2016 |
Lynch SM, Peek MK, Mitra N, Ravichandran K, Branas C, Spangler E, Zhou W, Paskett ED, Gehlert S, DeGraffinreid C, Rebbeck TR, Riethman H. Race, Ethnicity, Psychosocial Factors, and Telomere Length in a Multicenter Setting. Plos One. 11: e0146723. PMID 26752285 DOI: 10.1371/Journal.Pone.0146723 |
0.422 |
|
| 2016 |
Scales R, Spangler E, Morales K, Glanz K, Rebbeck T, Zeigler-Johnson C. Abstract A71: Modification of obesity associations with prostate cancer grade by area-level factors Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-A71 |
0.358 |
|
| 2016 |
Lynch S, Mitra N, Ross M, Newcomb C, Daily K, Jackson T, Zeigler-Johnson C, Riethman H, Branas C, Rebbeck T. Abstract 4351: A neighborhood-wide association study (NWAS) in prostate cancer: A new methodologic approach Cancer Research. 76: 4351-4351. DOI: 10.1158/1538-7445.Am2016-4351 |
0.572 |
|
| 2015 |
Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, Fan L, Kandalaft LE, Tanyi JL, Li C, Yuan CX, ... ... Rebbeck T, et al. Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell. 28: 529-40. PMID 26461095 DOI: 10.1016/J.Ccell.2015.09.006 |
0.335 |
|
| 2015 |
Nan H, Dorgan JF, Rebbeck TR. Genetic variants in hypothalamic-pituitary-adrenal axis genes and breast cancer risk in Caucasians and African Americans. International Journal of Molecular Epidemiology and Genetics. 6: 33-40. PMID 26417403 |
0.353 |
|
| 2015 |
Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR, Suneja G, Kayembe MK, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S. Cancer Incidence following Expansion of HIV Treatment in Botswana. Plos One. 10: e0135602. PMID 26267867 DOI: 10.1371/Journal.Pone.0135602 |
0.325 |
|
| 2015 |
Chai X, Domchek S, Kauff N, Rebbeck T, Chen J. RE: Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction. Journal of the National Cancer Institute. 107. PMID 26264690 DOI: 10.1093/Jnci/Djv033 |
0.411 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Rebbeck TR, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.317 |
|
| 2015 |
Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, Laitman Y, Kushnir A, Paluch-Shimon S, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. Jama. 313: 1347-61. PMID 25849179 DOI: 10.1001/Jama.2014.5985 |
0.5 |
|
| 2015 |
Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman CA, Schumacher FR, Pashayan N, Pharoah PD, ... ... Rebbeck TR, et al. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1121-9. PMID 25837820 DOI: 10.1158/1055-9965.Epi-14-0317 |
0.315 |
|
| 2015 |
Blanco I, Kuchenbaecker K, Cuadras D, Wang X, Barrowdale D, de Garibay GR, Librado P, Sánchez-Gracia A, Rozas J, Bonifaci N, McGuffog L, Pankratz VS, Islam A, Mateo F, Berenguer A, ... ... Rebbeck TR, et al. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers. Plos One. 10: e0120020. PMID 25830658 DOI: 10.1371/Journal.Pone.0120020 |
0.318 |
|
| 2015 |
Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, ... ... Rebbeck TR, et al. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Human Genetics. 134: 439-50. PMID 25715684 DOI: 10.1007/S00439-015-1534-9 |
0.308 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Rebbeck TR, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.32 |
|
| 2015 |
Lee G, Singanamalli A, Wang H, Feldman MD, Master SR, Shih NN, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A. Supervised multi-view canonical correlation analysis (sMVCCA): integrating histologic and proteomic features for predicting recurrent prostate cancer. Ieee Transactions On Medical Imaging. 34: 284-97. PMID 25203987 DOI: 10.1109/Tmi.2014.2355175 |
0.314 |
|
| 2015 |
Han Y, Signorello LB, Strom SS, Kittles RA, Rybicki BA, Stanford JL, Goodman PJ, Berndt SI, Carpten J, Casey G, Chu L, Conti DV, Rand KA, Diver WR, Hennis AJ, ... ... Rebbeck TR, et al. Generalizability of established prostate cancer risk variants in men of African ancestry. International Journal of Cancer. Journal International Du Cancer. 136: 1210-7. PMID 25044450 DOI: 10.1002/Ijc.29066 |
0.354 |
|
| 2015 |
Zeigler-Johnson CM, Morales K, Mitchell J, Spangler E, Glanz K, Rebbeck T. Abstract 3722: Modification of obesity effects on prostate cancer outcomes by age and education Cancer Research. 75: 3722-3722. DOI: 10.1158/1538-7445.Am2015-3722 |
0.376 |
|
| 2015 |
Spangler E, Zeigler-Johnson C, Mitchell J, Rebbeck T. Abstract 3720: Diabetes and prostate cancer (CaP): Clinical characteristics and disparity in outcomes Cancer Research. 75: 3720-3720. DOI: 10.1158/1538-7445.Am2015-3720 |
0.356 |
|
| 2015 |
Yamoah K, Johnson M, Choeurng V, Yousefi K, Haddad Z, Den R, Lal P, Feldman M, Dicker A, Klein E, Davicioni E, Rebbeck T, Schaeffer E. MP6-03 A NOVEL BIOMARKER SIGNATURE WHICH MAY PREDICT AGGRESSIVE DISEASE IN AFRICAN-AMERICAN MEN WITH PROSTATE CANCER Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.250 |
0.362 |
|
| 2014 |
Kuchenbaecker KB, Neuhausen SL, Robson M, Barrowdale D, McGuffog L, Mulligan AM, Andrulis IL, Spurdle AB, Schmidt MK, Schmutzler RK, Engel C, Wappenschmidt B, Nevanlinna H, Thomassen M, Southey M, ... ... Rebbeck TR, et al. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 16: 3416. PMID 25919761 DOI: 10.1186/S13058-014-0492-9 |
0.304 |
|
| 2014 |
Nan H, Dorgan JF, Rebbeck TR. Genetic variants in anti-Mullerian hormone and anti-Mullerian hormone receptor genes and breast cancer risk in Caucasians and African Americans. International Journal of Molecular Epidemiology and Genetics. 5: 145-51. PMID 25379134 |
0.341 |
|
| 2014 |
Lee G, Sparks R, Ali S, Shih NN, Feldman MD, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A. Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patients. Plos One. 9: e97954. PMID 24875018 DOI: 10.1371/Journal.Pone.0097954 |
0.391 |
|
| 2014 |
Chen MM, Crous-Bou M, Setiawan VW, Prescott J, Olson SH, Wentzensen N, Black A, Brinton L, Chen C, Chen C, Cook LS, Doherty J, Friedenreich CM, Hankinson SE, Hartge P, ... ... Rebbeck TR, et al. Exome-wide association study of endometrial cancer in a multiethnic population. Plos One. 9: e97045. PMID 24810602 DOI: 10.1371/Journal.Pone.0097045 |
0.323 |
|
| 2014 |
Osorio A, Milne RL, Kuchenbaecker K, Vaclová T, Pita G, Alonso R, Peterlongo P, Blanco I, de la Hoya M, Duran M, DÃez O, Ramón Y Cajal T, Konstantopoulou I, MartÃnez-Bouzas C, Andrés Conejero R, ... ... Rebbeck TR, et al. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. Plos Genetics. 10: e1004256. PMID 24698998 DOI: 10.1371/Journal.Pgen.1004256 |
0.338 |
|
| 2014 |
Margolis DJ, Gupta J, Apter AJ, Hoffstad O, Papadopoulos M, Rebbeck TR, Wubbenhorst B, Mitra N. Exome sequencing of filaggrin and related genes in African-American children with atopic dermatitis. The Journal of Investigative Dermatology. 134: 2272-4. PMID 24608987 DOI: 10.1038/Jid.2014.126 |
0.361 |
|
| 2014 |
Margolis DJ, Gupta J, Apter AJ, Ganguly T, Hoffstad O, Papadopoulos M, Rebbeck TR, Mitra N. Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects. The Journal of Allergy and Clinical Immunology. 133: 784-9. PMID 24184149 DOI: 10.1016/J.Jaci.2013.09.015 |
0.39 |
|
| 2013 |
Gabriel CA, Mitra N, Demichele A, Rebbeck T. Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women. Breast Cancer Research and Treatment. 139: 833-43. PMID 23764995 DOI: 10.1007/S10549-013-2592-0 |
0.587 |
|
| 2013 |
Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, Gaudet MM, Dicks E, Kosel M, Healey S, Sinilnikova OM, ... ... Rebbeck TR, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. Plos Genetics. 9: e1003212. PMID 23544013 DOI: 10.1371/Journal.Pgen.1003212 |
0.34 |
|
| 2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Rebbeck TR, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.303 |
|
| 2013 |
Zeigler-Johnson C, Morales KH, Spangler E, Chang BL, Rebbeck TR. Relationship of early-onset baldness to prostate cancer in African-American men. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 589-96. PMID 23532004 DOI: 10.1158/1055-9965.EPI-12-0944 |
0.305 |
|
| 2013 |
Zheng Y, Ogundiran TO, Falusi AG, Nathanson KL, John EM, Hennis AJ, Ambs S, Domchek SM, Rebbeck TR, Simon MS, Nemesure B, Wu SY, Leske MC, Odetunde A, Niu Q, et al. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. Carcinogenesis. 34: 1520-8. PMID 23475944 DOI: 10.1093/Carcin/Bgt090 |
0.337 |
|
| 2013 |
Suneja G, Dryden-Peterson S, Boyer M, Musimar Z, Nsingo-Bvochora M, Ramogola-Masire D, Medhin H, Bekelman J, Lockman S, Rebbeck T. Cancer in Botswana: A Prospective Cohort Study of Cancer Type, Treatment, and Outcomes International Journal of Radiation Oncology*Biology*Physics. 87: S492-S493. DOI: 10.1016/J.Ijrobp.2013.06.1302 |
0.367 |
|
| 2012 |
Zhao H, Rebbeck TR, Mitra N. Analyzing genetic association studies with an extended propensity score approach. Statistical Applications in Genetics and Molecular Biology. 11. PMID 23104843 DOI: 10.1515/1544-6115.1790 |
0.557 |
|
| 2012 |
Fernandez P, Zeigler-Johnson CM, Spangler E, van der Merwe A, Jalloh M, Gueye SM, Rebbeck TR. Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men. Prostate Cancer. 2012: 798634. PMID 23091730 DOI: 10.1155/2012/798634 |
0.325 |
|
| 2012 |
Stevens KN, Wang X, Fredericksen Z, Pankratz VS, Greene MH, Andrulis IL, Thomassen M, Caligo M, Nathanson KL, Jakubowska A, Osorio A, Hamann U, Godwin AK, Stoppa-Lyonnet D, ... ... Rebbeck TR, et al. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Breast Cancer Research and Treatment. 136: 295-302. PMID 23011509 DOI: 10.1007/S10549-012-2255-6 |
0.33 |
|
| 2012 |
Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, ... ... Rebbeck TR, et al. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1362-70. PMID 22729394 DOI: 10.1158/1055-9965.Epi-12-0229 |
0.33 |
|
| 2012 |
Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott RJ, McGuffog L, Healy S, Sinilnikova OM, Rennert G, Lejbkowicz F, Flugelman A, Andrulis IL, Glendon G, Ozcelik H, ... ... Rebbeck T, et al. Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. British Journal of Cancer. 106: 2016-24. PMID 22669161 DOI: 10.1038/Bjc.2012.160 |
0.414 |
|
| 2012 |
Finkelman BS, Rubinstein WS, Friedman S, Friebel TM, Dubitsky S, Schonberger NS, Shoretz R, Singer CF, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder C, Garber JE, ... ... Rebbeck TR, et al. Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1321-8. PMID 22430266 DOI: 10.1200/Jco.2011.37.8133 |
0.327 |
|
| 2012 |
Huo D, Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Niu Q, et al. Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis. 33: 835-40. PMID 22357627 DOI: 10.1093/Carcin/Bgs093 |
0.307 |
|
| 2012 |
Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, ... ... Rebbeck TR, et al. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 645-57. PMID 22351618 DOI: 10.1158/1055-9965.Epi-11-0888 |
0.326 |
|
| 2012 |
Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Healey S, Sinilnikova OM, Caligo MA, Loman N, Harbst K, Lindblom A, Arver B, ... ... Rebbeck T, et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research : Bcr. 14: R33. PMID 22348646 DOI: 10.1186/Bcr3121 |
0.395 |
|
| 2012 |
Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM, Healey S, Barrowdale D, Lee A, Thomassen M, Gerdes AM, Kruse TA, Jensen UB, ... ... Rebbeck TR, et al. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Human Mutation. 33: 690-702. PMID 22253144 DOI: 10.1002/Humu.22025 |
0.339 |
|
| 2012 |
Hou N, Zheng Y, Gamazon ER, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, et al. Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 552-6. PMID 22237986 DOI: 10.1158/1055-9965.Epi-11-0979 |
0.334 |
|
| 2012 |
Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Niu Q, Zhang J, et al. Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry. Breast Cancer Research and Treatment. 132: 341-5. PMID 22134622 DOI: 10.1007/S10549-011-1890-7 |
0.325 |
|
| 2012 |
Sepe DM, McWilliams T, Chen J, Kershenbaum A, Zhao H, La M, Devidas M, Lange B, Rebbeck TR, Aplenc R. Germline genetic variation and treatment response on CCG-1891. Pediatric Blood & Cancer. 58: 695-700. PMID 21618417 DOI: 10.1182/Blood.V116.21.2711.2711 |
0.592 |
|
| 2012 |
Margolis DJ, Mitra N, Sandilands A, McLean I, Rebbeck T. Filaggrin mutations: Prognosis and response to therapy overtime Journal of Investigative Dermatology. 132. DOI: 10.1038/Jid.2012.82 |
0.442 |
|
| 2011 |
Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M, Sherman M, Spurdle AB, Wappenschmidt B, Lee A, McGuffog L, Healey S, Sinilnikova OM, ... ... Rebbeck T, et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research : Bcr. 13: R110. PMID 22053997 DOI: 10.1186/Bcr3052 |
0.402 |
|
| 2011 |
Healey CS, Ahmed S, O'Mara TA, Ferguson K, Lambrechts D, Garcia-Dios DA, Vergote I, Amant F, Howarth K, Gorman M, Hodgson S, ... ... Rebbeck TR, et al. Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study. Carcinogenesis. 32: 1862-6. PMID 21965274 DOI: 10.1093/Carcin/Bgr214 |
0.344 |
|
| 2011 |
Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL, ... ... Rebbeck TR, et al. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human Molecular Genetics. 20: 4732-47. PMID 21890493 DOI: 10.1093/Hmg/Ddr388 |
0.316 |
|
| 2011 |
Chen F, Chen GK, Millikan RC, John EM, Ambrosone CB, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Deming SL, Bandera EV, Nyante S, Palmer JR, Rebbeck TR, Ingles SA, et al. Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. Human Molecular Genetics. 20: 4491-503. PMID 21852243 DOI: 10.1093/Hmg/Ddr367 |
0.318 |
|
| 2011 |
Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder CL, Garber JE, et al. Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Research. 71: 5792-805. PMID 21799032 DOI: 10.1158/0008-5472.Can-11-0773 |
0.528 |
|
| 2011 |
Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, Jackson M, Kidd LC, Kolb S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, ... ... Rebbeck TR, et al. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 32: 1361-5. PMID 21705483 DOI: 10.1093/Carcin/Bgr119 |
0.322 |
|
| 2011 |
Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nature Genetics. 43: 570-3. PMID 21602798 DOI: 10.1038/Ng.839 |
0.335 |
|
| 2011 |
Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini B, ... ... Rebbeck T, et al. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 20: 3304-21. PMID 21593217 DOI: 10.1093/Hmg/Ddr226 |
0.435 |
|
| 2011 |
Catalona WJ, Bailey-Wilson JE, Camp NJ, Chanock SJ, Cooney KA, Easton DF, Eeles RA, FitzGerald LM, Freedman ML, Gudmundsson J, Kittles RA, Margulies EH, McGuire BB, Ostrander EA, Rebbeck TR, et al. National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Research. 71: 3442-6. PMID 21558387 DOI: 10.1158/0008-5472.Can-11-0314 |
0.305 |
|
| 2011 |
Margolis DJ, Papadopoulos M, Apter AJ, McLean WH, Mitra N, Rebbeck TR. Obtaining DNA in the mail from a national sample of children with a chronic non-fatal illness. The Journal of Investigative Dermatology. 131: 1765-7. PMID 21509047 DOI: 10.1038/Jid.2011.102 |
0.403 |
|
| 2011 |
Barnholtz-Sloan JS, Guan X, Zeigler-Johnson C, Meropol NJ, Rebbeck TR. Decision tree-based modeling of androgen pathway genes and prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1146-55. PMID 21493872 DOI: 10.1158/1055-9965.Epi-10-0996 |
0.302 |
|
| 2011 |
Osorio A, Milne RL, Alonso R, Pita G, Peterlongo P, Teulé A, Nathanson KL, Domchek SM, Rebbeck T, Lasa A, Konstantopoulou I, Hogervorst FB, Verhoef S, van Dooren MF, Jager A, et al. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. British Journal of Cancer. 104: 1356-61. PMID 21427728 DOI: 10.1038/Bjc.2011.91 |
0.339 |
|
| 2011 |
Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM, Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I, O'Mara T, et al. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. Plos One. 6: e16756. PMID 21347432 DOI: 10.1371/Journal.Pone.0016756 |
0.302 |
|
| 2011 |
Ahn J, Kibel AS, Park JY, Rebbeck TR, Rennert H, Stanford JL, Ostrander EA, Chanock S, Wang MH, Mittal RD, Isaacs WB, Platz EA, Hayes RB. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1075-81. PMID 21343373 DOI: 10.1158/1078-0432.Ccr-10-0881 |
0.33 |
|
| 2011 |
Mao JJ, Su HI, Feng R, Donelson ML, Aplenc R, Rebbeck TR, Stanczyk F, DeMichele A. Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors. Breast Cancer Research : Bcr. 13: R8. PMID 21251330 DOI: 10.1186/Bcr2813 |
0.53 |
|
| 2011 |
O'Mara TA, Fahey P, Ferguson K, Marquart L, Lambrechts D, Despierre E, Vergote I, Amant F, Hall P, Liu J, Czene K, Rebbeck TR, et al. Progesterone receptor gene variants and risk of endometrial cancer. Carcinogenesis. 32: 331-5. PMID 21148628 DOI: 10.1093/carcin/bgq263 |
0.324 |
|
| 2011 |
Barnholtz-Sloan JS, Guan X, Zeigler-Johnson C, Meropol NJ, Rebbeck T. Abstract 2740: Decision tree-based modeling of androgen pathway genes and prostate cancer risk Cancer Research. 71: 2740-2740. DOI: 10.1158/1538-7445.Am2011-2740 |
0.433 |
|
| 2011 |
Lynch S, Tenhave T, Spangler E, Walker A, Zeigler-Johnson C, Rebbeck T. Abstract 1896: Simple mediation analysis to determine if MSMB is a prostate specific antigen (PSA) or prostate cancer (PC) gene Cancer Research. 71: 1896-1896. DOI: 10.1158/1538-7445.Am2011-1896 |
0.424 |
|
| 2010 |
Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Research. 70: 9742-54. PMID 21118973 DOI: 10.1158/0008-5472.Can-10-1907 |
0.336 |
|
| 2010 |
Walker LC, Fredericksen ZS, Wang X, Tarrell R, Pankratz VS, Lindor NM, Beesley J, Healey S, Chen X, Stoppa-Lyonnet D, Tirapo C, Giraud S, Mazoyer S, Muller D, ... ... Rebbeck T, et al. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research : Bcr. 12: R102. PMID 21114847 DOI: 10.1186/Bcr2785 |
0.387 |
|
| 2010 |
Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segrè AV, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, ... ... Rebbeck T, et al. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. Plos Genetics. 6: e1001183. PMID 21060860 DOI: 10.1371/Journal.Pgen.1001183 |
0.453 |
|
| 2010 |
Engel C, Versmold B, Wappenschmidt B, Simard J, Easton DF, Peock S, Cook M, Oliver C, Frost D, Mayes R, Evans DG, Eeles R, Paterson J, Brewer C, ... ... Rebbeck TR, et al. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2859-68. PMID 20978178 DOI: 10.1158/1055-9965.Epi-10-0517 |
0.346 |
|
| 2010 |
Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D, Peock S, Cook M, ... ... Rebbeck T, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature Genetics. 42: 885-92. PMID 20852631 DOI: 10.1038/Ng.669 |
0.433 |
|
| 2010 |
Gor PP, Su HI, Gray RJ, Gimotty PA, Horn M, Aplenc R, Vaughan WP, Tallman MS, Rebbeck TR, DeMichele A. Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast Cancer Research : Bcr. 12: R26. PMID 20459744 DOI: 10.1186/Bcr2570 |
0.509 |
|
| 2010 |
Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M, McGuffog L, Pharaoh PD, Ponder BA, Dunning AM, Peock S, Cook M, Oliver C, Frost D, Sinilnikova OM, ... ... Rebbeck TR, et al. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 19: 2886-97. PMID 20418484 DOI: 10.1093/Hmg/Ddq174 |
0.341 |
|
| 2010 |
Hirshfield KM, Rebbeck TR, Levine AJ. Germline mutations and polymorphisms in the origins of cancers in women. Journal of Oncology. 2010: 297671. PMID 20111735 DOI: 10.1155/2010/297671 |
0.305 |
|
| 2010 |
Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segrè AV, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, ... ... Rebbeck T, et al. Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer Plos Genetics. 6. DOI: 10.1371/Annotation/B28Cf02D-7196-4A16-8B36-6562A0B84F75 |
0.377 |
|
| 2010 |
Zeigler‐Johnson CM, Chang B, Panossian S, Spangler E, Malkowicz SB, Rebbeck T. Abstract B122: Multi‐SNP analysis of one‐carbon metabolism genes and prostate cancer outcomes Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B122 |
0.461 |
|
| 2010 |
Zeigler-Johnson CM, Liu Z, Spangler E, Rebbeck T. Abstract B69: Effects of obesity and neighborhood socioeconomic status on prostate cancer stage and grade Cancer Epidemiology, Biomarkers & Prevention. 19. DOI: 10.1158/1055-9965.Disp-10-B69 |
0.372 |
|
| 2009 |
Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, ... ... Rebbeck TR, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics. 41: 1116-21. PMID 19767753 DOI: 10.1038/Ng.450 |
0.303 |
|
| 2009 |
Rebbeck TR, Mitra N, Domchek SM, Wan F, Chuai S, Friebel TM, Panossian S, Spurdle A, Chenevix-Trench G, Singer CF, Pfeiler G, Neuhausen SL, Lynch HT, Garber JE, et al. Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Cancer Research. 69: 5801-10. PMID 19584272 DOI: 10.1158/0008-5472.Can-09-0625 |
0.541 |
|
| 2009 |
Zhao H, Rebbeck TR, Mitra N. A propensity score approach to correction for bias due to population stratification using genetic and non-genetic factors. Genetic Epidemiology. 33: 679-90. PMID 19353632 DOI: 10.1002/Gepi.20419 |
0.547 |
|
| 2009 |
Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers Journal of the National Cancer Institute. 101: 80-87. PMID 19141781 DOI: 10.1093/jnci/djn442 |
0.31 |
|
| 2009 |
Setiawan VW, Doherty JA, Shu XO, Akbari MR, Chen C, De Vivo I, Demichele A, Garcia-Closas M, Goodman MT, Haiman CA, Hankinson SE, Henderson BE, Horn-Ross PL, Lacey JV, Le Marchand L, ... ... Rebbeck TR, et al. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 242-7. PMID 19124504 DOI: 10.1158/1055-9965.Epi-08-0689 |
0.328 |
|
| 2008 |
Tan YC, Zeigler-Johnson C, Mittal RD, Mandhani A, Mital B, Rebbeck TR, Rennert H. Common 8q24 sequence variations are associated with Asian Indian advanced prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2431-5. PMID 18768513 DOI: 10.1158/1055-9965.EPI-07-2823 |
0.311 |
|
| 2008 |
DeMichele A, Troxel AB, Berlin JA, Weber AL, Bunin GR, Turzo E, Schinnar R, Burgh D, Berlin M, Rubin SC, Rebbeck TR, Strom BL. Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4151-9. PMID 18757329 DOI: 10.1200/Jco.2007.14.0921 |
0.307 |
|
| 2008 |
Wei Z, Li M, Rebbeck T, Li H. U-statistics-based tests for multiple genes in genetic association studies. Annals of Human Genetics. 72: 821-33. PMID 18691161 DOI: 10.1111/J.1469-1809.2008.00473.X |
0.353 |
|
| 2008 |
Apter AJ, Schelleman H, Walker A, Addya K, Rebbeck T. Clinical and genetic risk factors of self-reported penicillin allergy Journal of Allergy and Clinical Immunology. 122: 152-158. PMID 18538381 DOI: 10.1016/J.Jaci.2008.03.037 |
0.34 |
|
| 2008 |
Rennert H, Zeigler-Johnson C, Mittal RD, Tan YC, Sadowl CM, Edwards J, Finley MJ, Mandhani A, Mital B, Rebbeck TR. Analysis of the RNASEL/HPC1, and macrophage scavenger receptor 1 in Asian-Indian advanced prostate cancer. Urology. 72: 456-60. PMID 18436282 DOI: 10.1016/j.urology.2007.11.139 |
0.3 |
|
| 2008 |
Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, ... ... Rebbeck TR, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. American Journal of Human Genetics. 82: 937-48. PMID 18355772 DOI: 10.1016/J.Ajhg.2008.02.008 |
0.332 |
|
| 2007 |
DeMichele A, Gimotty P, Botbyl J, Aplenc R, Colligon T, Foulkes AS, Rebbeck TR. In response to "Drug metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort". Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5675-7. PMID 18065748 DOI: 10.1200/Jco.2006.10.1485 |
0.461 |
|
| 2007 |
Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, ... ... Rebbeck TR, et al. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1416-21. PMID 17627006 DOI: 10.1158/1055-9965.EPI-07-0129 |
0.319 |
|
| 2007 |
Rebbeck TR, Troxel AB, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Norman S, Bunin G, DeMichele A, Berlin M, Schinnar R, Berlin JA, Strom BL. Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 444-50. PMID 17372239 DOI: 10.1158/1055-9965.Epi-06-0800 |
0.313 |
|
| 2007 |
Domchek SM, Rebbeck TR. Prophylactic oophorectomy in women at increased cancer risk Current Opinion in Obstetrics and Gynecology. 19: 27-30. PMID 17218848 DOI: 10.1097/GCO.0b013e32801195da |
0.303 |
|
| 2007 |
Rebbeck TR, Troxel AB, Norman S, Bunin GR, DeMichele A, Baumgarten M, Berlin M, Schinnar R, Strom BL. A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. International Journal of Cancer. Journal International Du Cancer. 120: 1523-8. PMID 17205521 DOI: 10.1002/Ijc.22485 |
0.303 |
|
| 2007 |
Gor PP, Gray RJ, Horn M, Rebbeck TR, Gimotty PA, Aplenc R, Pins M, Tallman MS, DeMichele A. Association of polymorphic drug metabolizing enzymes (DME) with outcomes in breast cancer patients treated on the ECOG 2190/Intergroup 0121 (E2190/Int0121) study Journal of Clinical Oncology. 25: 596-596. DOI: 10.1200/Jco.2007.25.18_Suppl.596 |
0.485 |
|
| 2006 |
Rebbeck TR, Troxel AB, Wang Y, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Bunin G, DeMichele A, Rubin SC, Baumgarten M, Berlin M, Schinnar R, Berlin JA, et al. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. Journal of the National Cancer Institute. 98: 1311-20. PMID 16985250 DOI: 10.1093/Jnci/Djj360 |
0.487 |
|
| 2006 |
Wang Y, Localio R, Rebbeck TR. Evaluating bias due to population stratification in epidemiologic studies of gene-gene or gene-environment interactions. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 124-32. PMID 16434597 DOI: 10.1158/1055-9965.Epi-05-0304 |
0.407 |
|
| 2006 |
Kauff ND, Domchek SM, Friebel TM, Lee JB, Roth R, Robson ME, Barakat RR, Norton L, Offit K, Rebbeck TR. Multi-center prospective analysis of risk-reducing salpingo-oophorectomy to prevent BRCA-associated breast and ovarian cancer Journal of Clinical Oncology. 24: 1003-1003. DOI: 10.1200/jco.2006.24.18_suppl.1003 |
0.34 |
|
| 2006 |
Andreadis C, Gimotty P, Hammond R, Wahl P, Houldsworth J, Schuster S, Rebbeck T. Expression Levels of Glutathione Peroxidase 1 (GPx1) and Multi-Drug Resistance 1 (MDR1; ABCB1) Identify Patients with Diffuse Large B-Cell Lymphoma (DLBCL) That Have Superior Clinical Outcomes. Blood. 108: 839-839. DOI: 10.1182/Blood.V108.11.839.839 |
0.332 |
|
| 2005 |
Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Mitra N, Busam K, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample Journal of the National Cancer Institute. 97: 1507-1515. PMID 16234564 DOI: 10.1093/Jnci/Dji312 |
0.44 |
|
| 2005 |
Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K, Weber B, Rebbeck T, Neuhausen SL, Ghadirian P, Foulkes WD, Gershoni-Baruch R, Friedman E, Rennert G, Wagner T, et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7491-6. PMID 16234515 DOI: 10.1200/Jco.2004.00.7138 |
0.383 |
|
| 2005 |
DeMichele A, Aplenc R, Botbyl J, Colligan T, Wray L, Klein-Cabral M, Foulkes A, Gimotty P, Glick J, Weber B, Stadtmauer E, Rebbeck TR. Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5552-9. PMID 16110016 DOI: 10.1200/Jco.2005.06.208 |
0.503 |
|
| 2005 |
Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, Pfeiffer RM. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. Journal of the National Cancer Institute. 97: 998-1007. PMID 15998953 DOI: 10.1093/Jnci/Dji176 |
0.348 |
|
| 2005 |
Wang Y, Localio R, Rebbeck TR. Bias correction with a single null marker for population stratification in candidate gene association studies. Human Heredity. 59: 165-75. PMID 15920341 DOI: 10.1159/000085940 |
0.383 |
|
| 2005 |
Aplenc R, Thompson J, Han P, La M, Zhao H, Lange B, Rebbeck T. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Research. 65: 2482-7. PMID 15781665 DOI: 10.1158/0008-5472.Can-04-2606 |
0.634 |
|
| 2005 |
Demichele A, Troxel A, Weber A, Berlin J, Bunin G, Turzo E, Burgh D, Schinnar R, Rubin S, Rebbeck T, Strom B. Effect of raloxifene on endometrial cancer risk in a population-based, case-control study Journal of Clinical Oncology. 23: 5001-5001. DOI: 10.1200/Jco.2005.23.16_Suppl.5001 |
0.427 |
|
| 2004 |
Zeigler-Johnson C, Friebel T, Walker AH, Wang Y, Spangler E, Panossian S, Patacsil M, Aplenc R, Wein AJ, Malkowicz SB, Rebbeck TR. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Research. 64: 8461-7. PMID 15548719 DOI: 10.1158/0008-5472.Can-04-1651 |
0.605 |
|
| 2004 |
Huang J, Domchek SM, Brose MS, Rebbeck TR, Nathanson KL, Weber BL. Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers Journal of Medical Genetics. 41. PMID 15520402 DOI: 10.1136/Jmg.2004.022913 |
0.304 |
|
| 2004 |
Vogl FD, Taioli E, Maugard C, Zheng W, Ribeiro Pinto LF, Ambrosone C, Parl FF, Nedelcheva-Kristensen V, Rebbeck TR, Brennan P, Boffetta P. Glutathione S-transferases M1, T1, and P1 and breast cancer: A pooled analysis Cancer Epidemiology Biomarkers and Prevention. 13: 1473-1479. PMID 15342448 |
0.321 |
|
| 2004 |
Wang Y, Localio R, Rebbeck TR. Evaluating bias due to population stratification in case-control association studies of admixed populations. Genetic Epidemiology. 27: 14-20. PMID 15185399 DOI: 10.1002/Gepi.20003 |
0.424 |
|
| 2003 |
Aplenc R, Glatfelter W, Han P, Rappaport E, La M, Cnaan A, Blackwood MA, Lange B, Rebbeck T. CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia. British Journal of Haematology. 122: 240-4. PMID 12846892 DOI: 10.1046/J.1365-2141.2003.04430.X |
0.556 |
|
| 2003 |
Aplenc R, Zhao H, Rebbeck TR, Propert KJ. Group sequential methods and sample size savings in biomarker-disease association studies. Genetics. 163: 1215-9. PMID 12663557 |
0.591 |
|
| 2002 |
Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Cancer risk estimates for BCRA1 mutation carriers identified in a risk evaluation program Journal of the National Cancer Institute. 94: 1365-1372. PMID 12237282 DOI: 10.1093/Jnci/94.18.1365 |
0.326 |
|
| 2002 |
Aplenc R, Orudjev E, Swoyer J, Manke B, Rebbeck T. Differential bone marrow aspirate DNA yields from commercial extraction kits. Leukemia. 16: 1865-6. PMID 12200706 DOI: 10.1038/Sj.Leu.2402681 |
0.413 |
|
| 2002 |
Rebbeck TR. Inherited predisposition and breast cancer: Modifiers of BRCA1/2-associated breast cancer risk Environmental and Molecular Mutagenesis. 39: 228-234. PMID 11921193 DOI: 10.1002/em.10050 |
0.326 |
|
| 2001 |
Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI, Foulkes WD, Karlan B, ... ... Rebbeck T, et al. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics. 11: 635-8. PMID 11668223 DOI: 10.1097/00008571-200110000-00010 |
0.436 |
|
| 2001 |
Rebbeck TR, Wang Y, Kantoff PW, Krithivas K, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Brunet JS, Vesprini D, Garber JE, Lynch HT, Weber BL, Brown M. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Research. 61: 5420-4. PMID 11454686 |
0.499 |
|
| 2001 |
Fisher MJ, Virmani AK, Wu L, Aplenc R, Harper JC, Powell SM, Rebbeck TR, Sidransky D, Gazdar AF, El-Deiry WS. Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 1688-97. PMID 11410508 |
0.48 |
|
| 2001 |
Nathanson KL, Omaruddin R, Malkowicz SB, Rebbeck TR. An intronic variant in PTEN is not associated with prostate cancer risk Cancer Epidemiology Biomarkers and Prevention. 10: 277-278. PMID 11303600 |
0.307 |
|
| 2000 |
Friedman D, Thompson S, Yasui Y, Bunin G, Rebbeck T, Nichols K, Potter J, Meadows A. Genetic risk factors for second malignancy Journal of Pediatric Hematology/Oncology. 22: 368. DOI: 10.1097/00043426-200007000-00028 |
0.303 |
|
| 1999 |
Carroll BT, Couch FJ, Rebbeck TR, Weber BL. Polymorphisms in PTEN in breast cancer families Journal of Medical Genetics. 36: 94-96. PMID 10051004 DOI: 10.1136/Jmg.36.2.94 |
0.308 |
|
| 1999 |
Rebbeck TR. Inherited genetic predisposition in breast cancer: A population-based perspective Cancer. 86: 1673-1681. |
0.316 |
|
| 1998 |
Rebbeck TR, Rogatko A, Viana MAG. Evaluation of genotype data in clinical risk assessment: Methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer Genetic Testing. 1: 157-164. PMID 10464641 |
0.34 |
|
| 1998 |
Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB. P53 germline polymorphisms are associated with an increased risk for breast cancer in German women Anticancer Research. 18: 2095-2099. PMID 9677474 |
0.317 |
|
| 1997 |
Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility Cancer Epidemiology Biomarkers and Prevention. 6: 733-743. PMID 9298582 |
0.342 |
|
| 1997 |
Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. The New England Journal of Medicine. 336: 1409-15. PMID 9145677 DOI: 10.1056/Nejm199705153362002 |
0.391 |
|
| 1996 |
Rebbeck TR, Turner ST, Sing CF. Probability of having hypertension: Effects of sex, history of hypertension in parents, and other risk factors Journal of Clinical Epidemiology. 49: 727-734. PMID 8691221 DOI: 10.1016/0895-4356(96)00015-7 |
0.533 |
|
| 1996 |
Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, Cannon-Albright L, Larsson C, Goldgar DE, Narod SA. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nature Genetics. 12: 309-11. PMID 8589723 DOI: 10.1038/Ng0396-309 |
0.358 |
|
| 1995 |
Rogatko A, Rebbeck T, Zacks S. Risk prediction with linked markers: Pedigree analysis American Journal of Medical Genetics. 59: 24-32. PMID 8849005 DOI: 10.1002/Ajmg.1320590106 |
0.333 |
|
| 1993 |
Rebbeck TR, Turner ST, Sing CF. Sodium-lithium countertransport genotype and the probability of hypertension in adults Hypertension. 22: 560-568. PMID 8406661 DOI: 10.1161/01.Hyp.22.4.560 |
0.537 |
|
| 1992 |
Turner ST, Rebbeck TR, Sing CF. Sodium-lithium countertransport and probability of hypertension in caucasians 47 to 89 years old Hypertension. 20: 841-850. PMID 1452301 |
0.529 |
|
| Show low-probability matches. |